Diabetes Monitoring for People With Diabetes and Schizophrenia (SMD)

The percentage of persons 18–64 years of age with schizophrenia or schizoaffective disorder and diabetes who had both an LDL-C test and an HbA1c test during the measurement period. 

Why It Matters

An estimated 33.4% of people with schizophrenia have metabolic syndrome—a rate nearly two times higher than that of the general population (1).  

Among patients with co-occurring schizophrenia and metabolic disorders, the nontreatment rate for (trc)diabetes is approximately 30% (2). In addition to general diabetes risk factors, diabetes is promoted in patients with schizophrenia by initial and current treatment with olanzapine and mid-potency first-generation antipsychotics (FGA), as well as by current treatment with low-potency FGAs and clozapine (1). 

Improving blood sugar control has shown to lead to lower use of health care services and better overall satisfaction with diabetes treatment (3). People who control their diabetes also report improved quality of life and emotional well-being (4). 

Historical Results – National Averages

Get Access to the Historical Results

By completing the form below, you’ll gain free access to national performance data.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

References

  1. Nielsen, J., S. Skadhede, C.U. Correll. 2010. “Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naive Schizophrenia Patients.” Neuropsychopharmacology 35(9):1997–2004. 
  2. Nasrallah, H.A., J.M. Meyer, D.C. Goff, J.P. McEvoy, S.M. Davis, T.S. Stroup, et al. 2006. “Low Rates of Treatment for Hypertension, Dyslipidemia and Diabetes in Schizophrenia: Data from the CATIE Schizophrenia Trial Sample at Baseline.” Schizophr Res 86(1-3): 15–22. 
  3. Asche, C.J., C. LaFleur, C. Conner. 2011. “A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes.” Clinical Therapeutics 33(1):74–109. 
  4. Saatci, E., G. Tahmiscioglu, N. Bozdemir, et al. 2010. “The Well-Being and Treatment Satisfaction of Diabetic Patients in Primary Care.” Health Quality of Life Outcomes 8:67. 

  • Save
  • Email
  • Print